Diabetes insipidus (DI) is a condition where water in the body is improperly removed from the circulatory system by the kidneys.
There are 2 forms of DI:
Antidiuretic hormone (ADH) controls the amount of water reabsorbed by the kidneys. ADH is made in the hypothalamus of the brain. The pituitary gland, at the base of the brain, stores and releases ADH.
Central DI occurs when the hypothalamus does not make enough ADH.
NDI occurs when the kidneys do not respond to ADH.
Some diabetes insipidus is caused by genetic problems that lead to central DI or NDI. Others may develop after an injury or illness.
Factors that may increase your risk of DI include:
Symptoms may include:
You will be asked about your symptoms and medical history. A physical exam may be done.
Your bodily fluids may be tested. This can be done with:
Images may be taken of your bodily structures. This can be done with an MRI scan.
Talk with your doctor about the best plan for you. Your doctor will work with you to address the underlying cause.
Treatment may include:
American Diabetes Association
Nephrogenic Diabetes Insipidus Foundation
Canadian Diabetes Association
Central diabetes insipidus. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T115774/Central-diabetes-insipidus. Updated January 13, 2014. Accessed September 26, 2016.
Garofeanu CG, Weir M, Rosas-Arellano MP, et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis. 2005;45(4):626-637.
Majzoub JA, Srivatsa A. Diabetes insipidus: clinical and basic aspects. Pediatr Endocrinol Rev. 2006;Suppl 1:60-65.
Nephrogenic diabetes insipidus. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T116727/Nephrogenic-diabetes-insipidus. Updated November 20, 2013. Accessed September 26, 2016.
Rivkees SA, Dunbar N, Wilson TA. The management of central diabetes insipidus in infancy: desmopressin, low renal solue load formula, thazide diuretics. J Pediatr Endocrinol Metab. 2007;20(4):459-469.
Sands JM, Bichet DG. Nephogenic diabetes insipidus. Annals Int Med. 2006;144(3):186-194.
Toumba M, Stanhope R. Morbidity and mortality associated with vasopressin analogue treatment. Pediatr Endocrinol Metab. 2006;19(3):197-201.
Last reviewed September 2016 by Kim Carmichael, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.